🔎 Trials Near Me

Akèy › Sendwòm myelodisplastik › Illinois › Springfield

Etid klinik pou Sendwòm myelodisplastik nan Springfield, IL

3 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan ak bò kote Springfield (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06577441

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Southern Illinois University School of Medicine, Springfield
  • Springfield Clinic, Springfield
  • Springfield Memorial Hospital, Springfield
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

Etid Sendwòm myelodisplastik nan lòt vil

Lòt etid nan Springfield

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.